Dishman Carbogen Amcis (540701) Stock Overview
Provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
540701 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Dishman Carbogen Amcis Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹253.75 |
| 52 Week High | ₹321.15 |
| 52 Week Low | ₹180.00 |
| Beta | 0.35 |
| 1 Month Change | -4.12% |
| 3 Month Change | -8.66% |
| 1 Year Change | 2.88% |
| 3 Year Change | 191.83% |
| 5 Year Change | 86.65% |
| Change since IPO | -27.76% |
Recent News & Updates
Recent updates
Shareholder Returns
| 540701 | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -1.5% | -4.1% | 0.02% |
| 1Y | 2.9% | -2.3% | 4.0% |
Return vs Industry: 540701 exceeded the Indian Life Sciences industry which returned -0.4% over the past year.
Return vs Market: 540701 underperformed the Indian Market which returned 4.2% over the past year.
Price Volatility
| 540701 volatility | |
|---|---|
| 540701 Average Weekly Movement | 7.3% |
| Life Sciences Industry Average Movement | 4.7% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in IN Market | 8.4% |
| 10% least volatile stocks in IN Market | 3.1% |
Stable Share Price: 540701's share price has been volatile over the past 3 months compared to the Indian market.
Volatility Over Time: 540701's weekly volatility (7%) has been stable over the past year, but is still higher than 75% of Indian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 1,106 | Arpit Vyas | imdcal.com |
Dishman Carbogen Amcis Limited provides contract research and manufacturing services for the pharmaceutical and healthcare industries worldwide. The company operates through Contract Research and Manufacturing Services and Marketable Molecules segments. It offers cholesterol and vitamin D analogs; generic active pharmaceutical ingredients for diagnostics, ophthalmic treatments, laxatives, organophosphate antidotes; ammonium, phosphonium; quats, phosphoranes, and wittig reagents; cholesterol and lanolin-related products; sterile injectables; and softgel formulations, as well as hand and body wash, sanitisers, and antiseptics.
Dishman Carbogen Amcis Limited Fundamentals Summary
| 540701 fundamental statistics | |
|---|---|
| Market cap | ₹39.84b |
| Earnings (TTM) | ₹1.36b |
| Revenue (TTM) | ₹27.59b |
Is 540701 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 540701 income statement (TTM) | |
|---|---|
| Revenue | ₹27.59b |
| Cost of Revenue | ₹5.13b |
| Gross Profit | ₹22.47b |
| Other Expenses | ₹21.10b |
| Earnings | ₹1.36b |
Last Reported Earnings
Sep 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 8.70 |
| Gross Margin | 81.43% |
| Net Profit Margin | 4.94% |
| Debt/Equity Ratio | 35.3% |
How did 540701 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/16 11:44 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Dishman Carbogen Amcis Limited is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Shikha Jain | Anand Rathi Shares and Stock Brokers Limited |
| Nikhil Shetty | BP Wealth Management Private Limited |
| Nitin Agarwal | DAM Capital Advisors |